Frances R. Levin, MD
Frances Rudnick Levin, MD is the Kennedy-Leavy Professor of Psychiatry at Columbia University and the Chief of the Division on Substance Use Disorders at NYSPI/Columbia University. For the past 19 years she has been the Director of the Addiction Psychiatry Fellowship Program at New York Presbyterian Hospital and for the past 13 years, she has been the PI of a T32 NIDA funded Substance Abuse Research Fellowship. Dr. Levin graduated from Cornell University Medical College and completed her psychiatric residency at the New York Hospital-Payne Whitney Clinic. She is Medical Director of the Providers’ Clinical Support System- Medication Assisted Treatments (PCSS-MAT), a national training and mentoring initiative focused on addressing prescription opioid misuse.
She is the principal investigator on several federally funded grants, a U54 Medications Development grant evaluating novel treatments for opiate and cannabis use disorders, a T32 NIDA funded Substance Abuse Research Fellowship, and a K24 Mid-Career Investigator Award and collaborates on several other grants. Her research interests include pharmacologic and psychotherapeutic treatment interventions for cocaine and marijuana use disorder, and treatment approaches for adults with substance use disorders and attention-deficit hyperactivity disorder along with other psychiatric illnesses. Dr. Levin has over 200 articles and book chapters on a wide range of topics including treatments of substance use disorders, assessment and treatment of co-occurring psychiatric illnesses and vulnerabilities associated with substance use disorders. She has served on several advisory panels and ad-hoc federal grant review groups and was as a member of the NIDA – Initial Review Group: Training and Career Development Subcommittee for 8 years and served as a member to the NIDA Interventions to Prevent and Treat Addiction (IPTA). She is an editorial board member of three journals, past President of the American Academy of Addiction Psychiatry and past Chair of the APA Council on Addiction Psychiatry.